EconPapers    
Economics at your fingertips  
 

Vaccine Equivalence and Noninferiority Immunogenicity Trials

Jozef Nauta ()
Additional contact information
Jozef Nauta: Global Statistics, Solvay Pharmaceuticals

Chapter Chapter 6 in Statistics in Clinical Vaccine Trials, 2011, pp 67-84 from Springer

Abstract: Abstract Many vaccine immunogenicity trials are conducted in an equivalence or noninferiority framework. The objective of such trials is to demonstrate that the immunogenicity of an investigational vaccine is comparable or not less than that of a control vaccine. Four types of vaccine equivalence and noninferiority designs can be distinguished: vaccine bridging trials, combination vaccine trials, vaccine concomitant use trials and vaccine lot consistency trials. In this chapter the statistical analysis of the data of such trials is covered, both for trials with a geometric mean response as endpoint and trials with seroprotection or seroconversion as endpoint. The standard analysis of lot consistency data is known to be conservative, but a simple formula is presented which can be used to decide if the lot sample sizes guarantee that the actual type I error rate of the trial is sufficiently close to the nominal level. The chapter is concluded with a discussion of sample size estimation for vaccine equivalence and noninferiority trials, including lot consistency trials. Recommendations are given how to avoid that the statistical power is overestimated.

Keywords: Sample Size Estimation; Equivalence Trial; Combination Vaccine; Equivalence Range; Superiority Trial (search for similar items in EconPapers)
Date: 2011
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-14691-6_6

Ordering information: This item can be ordered from
http://www.springer.com/9783642146916

DOI: 10.1007/978-3-642-14691-6_6

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2026-07-28
Handle: RePEc:spr:sprchp:978-3-642-14691-6_6